SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-18-017281
Filing Date
2018-12-13
Accepted
2018-12-13 06:03:45
Documents
3
Period of Report
2018-12-13

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k121318_therapix.htm 6-K 18459
2 PRESS RELEASE DATED DECEMBER 11, 2018 f6k121318ex99-1_therapix.htm EX-99.1 8492
3 GRAPHIC ex99_001.jpg GRAPHIC 7526
  Complete submission text file 0001213900-18-017281.txt   38513
Mailing Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047
Business Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 181232110
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1